Search research articles
Contact Us
Filters
Showing results (61-70 of 275) with videos related to
Page
of 28
Sort By:
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1979
[Chromatin proteins and genetic control]
J Kruh, N Defer, A Kitzis, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1990
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria
M D Kitzis, F W Goldstein, M Miégi, et al.
Nephron. Clinical Practice
|
April 26, 2005
Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal disease
Gideon Charach, Itamar Grosskopf, Heschi H Rotmensch, et al.
Scandinavian Journal of Infectious Diseases
|
September 30, 2006
Hip arthroplasty infection with heterogeneous vancomycin-resistant Staphylococcus aureus
Valérie Zeller, Marie-Dominique Kitzis, Wilfrid Graff, et al.
Journal Des Maladies Vasculaires
|
January 1, 1994
["Logic" and doubts in the surgery of associated carotid and vertebral lesions]
B Andreassian, S Bouttier, G Leseche, et al.
The Journal of Infectious Diseases
|
July 9, 1999
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis
C Janoir, I Podglajen, M D Kitzis, et al.
La Nouvelle Presse Medicale
|
September 25, 1982
[Ureterovesical reimplantation. A technic derived from Lich and Gregoir's procedure]
O Briand, O Nussaume, G Cohen, et al.
Journal of Cell Science
|
March 1, 1995
In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors
T Mahdi, A Brizard, C Millet, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1996
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA
C Janoir, V Zeller, M D Kitzis, et al.
Pathologie-Biologie
|
May 1, 1991
[In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve]
C J Soussy, M D Kitzis, C Chanal, et al.
Page
of 28
Search research articles
Search
Showing results (61-70 of 275) with videos related to
Sort By:
Page
of 28
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1979
[Chromatin proteins and genetic control]
J Kruh, N Defer, A Kitzis, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1990
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria
M D Kitzis, F W Goldstein, M Miégi, et al.
Nephron. Clinical Practice
|
April 26, 2005
Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal disease
Gideon Charach, Itamar Grosskopf, Heschi H Rotmensch, et al.
Scandinavian Journal of Infectious Diseases
|
September 30, 2006
Hip arthroplasty infection with heterogeneous vancomycin-resistant Staphylococcus aureus
Valérie Zeller, Marie-Dominique Kitzis, Wilfrid Graff, et al.
Journal Des Maladies Vasculaires
|
January 1, 1994
["Logic" and doubts in the surgery of associated carotid and vertebral lesions]
B Andreassian, S Bouttier, G Leseche, et al.
The Journal of Infectious Diseases
|
July 9, 1999
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis
C Janoir, I Podglajen, M D Kitzis, et al.
La Nouvelle Presse Medicale
|
September 25, 1982
[Ureterovesical reimplantation. A technic derived from Lich and Gregoir's procedure]
O Briand, O Nussaume, G Cohen, et al.
Journal of Cell Science
|
March 1, 1995
In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors
T Mahdi, A Brizard, C Millet, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1996
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA
C Janoir, V Zeller, M D Kitzis, et al.
Pathologie-Biologie
|
May 1, 1991
[In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve]
C J Soussy, M D Kitzis, C Chanal, et al.
Page
of 28